Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Walgreens cuts Cencora stake further in $674 million share sale

Published 11/09/2023, 08:16 PM
Updated 11/09/2023, 08:20 PM
© Reuters. FILE PHOTO: Pigeons are seen resting on signage for Walgreens, owned by the Walgreens Boots Alliance, Inc., in Manhattan, New York City, U.S., November 26, 2021. REUTERS/Andrew Kelly/File Photo

(Reuters) - Walgreens Boots Alliance (NASDAQ:WBA) has further lowered its stake in Cencora, formerly known as AmerisourceBergen (NYSE:COR) Corp, by selling shares worth about $674 million, the U.S. drugstore chain said on Thursday.

After the share repurchase, Walgreens now owns approximately 15% in drug distributor Cencora, it said, adding that it would use the proceeds to pay down debt. Walgreens still remains Cencora's largest shareholder.

AmerisourceBergen disclosed plans early this year to rename itself as Cencora in a bid to expand internationally beyond drug distribution. The company adopted the name in the second half of 2023.

Walgreens has been reducing its stake in Cencora over time. Walgreens sold some shares of Cencora for proceeds of about $1.85 billion in August.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.